Mednet Logo
HomeGynecologic Oncology
Gynecologic Oncology

Gynecologic Oncology

Clinical discussions on gynecologic malignancies, surgical approaches, and multimodal treatment strategies.

Recent Discussions

How do you counsel a cervical cancer patient s/p definitive chemoRT who is not sexually active and refuses to use vaginal dilators to improve compliance?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Texas MD Anderson Cancer Center

There isn't much you can do except talk with them about the reasons for non-compliance (has it been painful, embarrassing, discuss rationale and encourage them. Are they unsure how to use it?- having them insert it during their clinic exam may help. If the dilator is causing pain, lubricants or vagi...

How do you counsel patients regarding adjuvant therapy for stage IA uterine serous carcinoma confined to a polyp?

3 Answers

Mednet Member
Mednet Member
Gynecologic Oncology · Memorial Sloan Kettering Cancer Center

Observation, if fully staged is acceptable. Consider that, in the case with no residual we recommend no chemo. So, if this patient had a hysteroscopic polypectomy and then hyst with no residual we would say no chemo but, the same patient, no polypectomy, we say chemo? Biologically, are the same.

Under what circumstances (if any) would you offer hysterectomy after completion of primary chemoradiation for locally advanced cervical cancer?

2 Answers

Mednet Member
Mednet Member
Gynecologic Oncology · Cooper Medical School of Rowan University

Very few. I have only done this once for someone with recurrence limited to the cervix. The patient refused exenterative surgery and we were lucky that the planes were preserved to perform the hysterectomy after full dose external beam and brachytherapy.

What dose is needed for salvage RT for recurrent endometrial cancer in untreated PA region (who has received pelvic RT) after good PET response to systemic therapy?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

I usually treat 45 Gy in 25 fraction to chain, and 55 in 25 to residual normalized node.

How would you approach a diagnostic excisional procedure for a pregnant patient with exam concerning for carcinoma and cervical biopsies (x 2) suspicious for foci of invasive disease?

1 Answers

Mednet Member
Mednet Member
Gynecologic Oncology · Medical University of South Carolina

First of all, I am very conservative in the management of cervical ca in pregnancy. Having said that, it appears that with a lesion I assume it was what was biopsied and showed questionable invasivion. I would re-biopsy the lesion, getting a good bite out of the lesion. If this is cancer you should ...

How would you counsel a patient with incidental diagnosis of at least high intermediate risk endometrial cancer, found on robotic hysterectomy with non-contained uterine morcellation and no node sampling?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Vanderbilt-Ingram Cancer Center

MELF pattern of invasion has a higher rate of LN involvement, reported as 18% in one series (Joehlin-Price et al., PMID 27740968) and as high as 54% in an older series (Pavlakis et al., PMID 21438907).In the setting of an unstaged patient, a discussion of lymphadenectomy vs whole pelvis RT would be ...

How would you manage a patient with 1B2 adenocarcinoma of the endocervix s/p TAH/BSO who was found to have bilateral metastasis to Fallopian tube, a 1 cm pelvic side wall metastasis, and no LN metastasis?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

We treat these patients like high-risk post op cervical cancer with concurrent chemo RT with weekly cisplatinum. We also discuss the option of adding adjuvant chemo after chemo RT with taxol and carboplatinum.

What is your preferred management for a patient who was treated with definitive chemoradiation for locally advanced cervical cancer who now has a biopsy-proven isolated brain metastasis 5 years later?

1 Answers

Mednet Member
Mednet Member
Gynecologic Oncology · Cooper Medical School of Rowan University

This is a rare occurrence, and there is no prospective clinical trial data that I am aware of to guide recommendations. In the literature, most seem to advocate for multimodal therapy with resection or stereotactic radiosurgery followed by whole brain radiotherapy for solitary brain lesions without ...

What dose and target volume do you use for neoadjuvant chemoRT in a patient with a locally advanced uterine/endometrial cancer involving parametria, cervix, and the uterine fundus (no side wall involvement) requiring downstage to be eligible for surgery?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Vanderbilt-Ingram Cancer Center

Presuming that this is an endometrioid cancer - I would start with RT +/- chemo. There is potential for there to be sufficient shrinkage to facilitate brachytherapy boost. I do appreciate the link Dr. @Dr. First Last published, and would consider doing SBRT with a neoadjuvant dose how we would as pe...

What are your image guidance instructions for post-op endometrial cancer EBRT?

5 Answers

Mednet Member
Mednet Member
Radiation Oncology · Sunnybrook Health Sciences Centre

We treat all these patients with IMRT now and they are simulated with full and empty bladder. We do not place any fiducials as they tend not to stay in place. Patients are always treated with full bladder and empty rectum (as much as possible). Daily CBCT is used for matching bladder and rectum an...